Advertisement
Heart, Lung and Circulation
Advanced searchSave search
Editorial| Volume 27, ISSUE 6, P652-655, June 2018

Atrial Fibrillation, an Under-Appreciated Reversible Cause of Cardiomyopathy: Implications for Clinical Practice From the CAMERA-MRI Study

  • Sandeep Prabhu
    Affiliations
    Department of Cardiology, Alfred Hospital, Melbourne, Vic, Australia

    Baker IDI Heart and Diabetes Institute, Melbourne, Vic, Australia

    Cardiology Department, Royal Melbourne Hospital, Melbourne, Vic, Australia

    Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Melbourne, Vic, Australia
    Search for articles by this author
  • Peter M. Kistler
    Correspondence
    Corresponding author at: Head Clinical Electrophysiology, The Heart Centre, The Alfred Hospital, Commercial Road, Melbourne, Victoria, Australia, 3004. Tel.: +61 3 9076 2000; fax: +61 3 9076 2461.
    Affiliations
    Department of Cardiology, Alfred Hospital, Melbourne, Vic, Australia

    Baker IDI Heart and Diabetes Institute, Melbourne, Vic, Australia

    Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Melbourne, Vic, Australia
    Search for articles by this author
DOI:https://doi.org/10.1016/S1443-9506(18)30152-5
Atrial Fibrillation, an Under-Appreciated Reversible Cause of Cardiomyopathy: Implications for Clinical Practice From the CAMERA-MRI Study
Previous ArticleHow Can You Have a Myocardial Infarction Without Significant Coronary Artery Disease? Whither MINOCA
Next ArticleCost-Effectiveness of Simvastatin Plus Ezetimibe for Cardiovascular Prevention in Patients With a History of Acute Coronary Syndrome: Analysis of Results of the IMPROVE-IT Trial
      Atrial fibrillation (AF) and left ventricular systolic dysfunction (LVSD) are two cardiovascular conditions that are increasing in incidence worldwide [
      • Chugh S.S.
      • Havmoeller R.
      • Narayanan K.
      • Singh D.
      • Rienstra M.
      • Benjamin E.J.
      • et al.
      Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.
      Circulation. 2014; 129: 837-847
      ]. Both conditions are associated with worsened survival and morbidity, in addition to significant economic burdens upon health care systems [
      • Cook C.
      • Cole G.
      • Asaria P.
      • Jabbour R.
      • Francis D.P.
      The annual global economic burden of heart failure.
      International Journal of Cardiology. 2014; 171: 368-376
      ]. Shared pathophysiological mechanisms mean that each condition can perpetuate the other, often making the temporal relationship between the two difficult to determine [
      • Prabhu S.
      • Voskoboinik A.
      • Kaye D.M.
      • Kistler P.M.
      Atrial Fibrillation and Heart Failure; Cause or Effect?.
      Heart, Lung and Circulation. 2017;
      ]. Nonetheless, such a distinction may be critical, particularly where AF is driving the LVSD, as treatment of the AF may potentially improve or even reverse the LVSD.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Chugh S.S.
        • Havmoeller R.
        • Narayanan K.
        • Singh D.
        • Rienstra M.
        • Benjamin E.J.
        • et al.
        Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.
        Circulation. 2014; 129: 837-847
        View in Article
        • Cook C.
        • Cole G.
        • Asaria P.
        • Jabbour R.
        • Francis D.P.
        The annual global economic burden of heart failure.
        International Journal of Cardiology. 2014; 171: 368-376
        View in Article
        • Prabhu S.
        • Voskoboinik A.
        • Kaye D.M.
        • Kistler P.M.
        Atrial Fibrillation and Heart Failure; Cause or Effect?.
        Heart, Lung and Circulation. 2017;
        View in Article
        • Wyse D.G.
        • Waldo A.L.
        • DiMarco J.P.
        • Domanski M.J.
        • Rsenberg Y.
        • Schron E.B.
        • et al.
        Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation.
        The New England Journal of Medicine. 2002; 347: 1825-1833
        View in Article
        • Roy D.
        • Talajic M.
        • Nattel S.
        • Wyse D.G.
        • Dorian P.
        • Lee K.L.
        • et al.
        Atrial Fibrillation and Congestive Heart Failure Investigators, Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure.
        New England Journal of Medicine. 2008; 358: 2667-2677
        View in Article
        • Di Biase L.
        • Mohanty P.
        • Mohanty S.
        • Santangeli P.
        • Trivedi C.
        • Lakkireddy D.
        • et al.
        Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial.
        Circulation. 2016; 133: 1637-1644
        View in Article
        • Hunter R.J.
        • Berriman T.J.
        • Diab I.
        • Kamdar R.
        • Richmond L.
        • Baker V.
        • et al.
        A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial).
        Circulation Arrhythmia and Electrophysiology. 2014; 7: 31-38
        View in Article
        • Khan M.N.
        • Jais P.
        • Cummings J.
        • Di Biase L.
        • Sanders P.
        • Martin D.O.
        • et al.
        PABA-CNF Investigators. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure.
        The New England Journal of Medicine. 2008; 359: 1778-1785
        View in Article
        • Jones D.G.
        • Haldar S.K.
        • Hussain W.
        • Sharma R.
        • Francis D.P.
        • Rahman-Haley S.L.
        • et al.
        A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure.
        Journal of the American College of Cardiology. 2013; 61: 1894-1903
        View in Article
        • Anselmino M.
        • Matta M.
        • D’Ascenzo F.
        • Bunch T.J.
        • Schilling R.J.
        • Hunter R.J.
        • et al.
        Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis.
        Circulation Arrhythmia and Electrophysiology. 2014; 7: 1011-1018
        View in Article
        • Prabhu S.
        • Taylor A.J.
        • Costello B.T.
        • Kaye D.M.
        • McLellan A.J.A.
        • Voskoboinik A.
        • et al.
        Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction: The CAMERA-MRI Study.
        Journal of the American College of Cardiology. 2017; 70: 1949-1961
        View in Article
        • Medi C.
        • Kalman J.M.
        • Haqqani H.
        • Vohra J.K.
        • Morton J.B.
        • Sparks P.B.
        • Kistler P.M.
        Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation.
        Journal of the American College of Cardiology. 2009; 53: 1791-1797
        View in Article
        • Ling L.H.
        • Khammy O.
        • Byrne M.
        • Amirahmadi F.
        • Foster A.
        • Li G.
        • et al.
        Irregular rhythm adversely influences calcium handling in ventricular myocardium: implications for the interaction between heart failure and atrial fibrillation.
        Circulation Heart failure. 2012; 5: 786-793
        View in Article
        • Naito M.
        • David D.
        • Michelson E.L.
        • Schaffenburg M.
        • Dreifus L.S.
        The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model.
        American Heart Journal. 1983; 106: 284-291
        View in Article
        • Benchimol A.
        • Duenas A.
        • Liggett M.S.
        • Dimond E.G.
        Contribution of atrial systole to the cardiac function at a fixed and at a variable ventricular rate.
        American Journal of Cardiology. 1965; 16: 11-21
        View in Article
        • Ullah W.
        • Ling L.H.
        • Prabhu S.
        • Lee G.
        • Kistler P.
        • Finlay M.C.
        • et al.
        Catheter ablation of atrial fibrillation in patients with heart failure: impact of maintaining sinus rhythm on heart failure status and long-term rates of stroke and death.
        Europace: European pacing, arrhythmias, and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2016; 18: 679-686
        View in Article
        • Prabhu S.
        • Voskoboinik A.
        • McLellan A.J.A.
        • Peck K.Y.
        • Pathik B.
        • Nalliah C.J.
        • et al.
        Biatrial Electrical and Structural Atrial Changes in Heart Failure: Electroanatomic Mapping in Persistent Atrial Fibrillation in Humans.
        JACC: Clinical Electrophysiology. 2018; 4: 87-96
        View in Article
        • Marrouche N.F.
        • Brachmann J.
        • Andresen D.
        • Siebels J.
        • Boersma L.
        • Jordaens L.
        • et al.
        CASTLE-AF Investigators. Catheter Ablation for Atrial Fibrillation with Heart Failure.
        The New England Journal of Medicine. 2018; 378: 417-427
        View in Article
        • Prabhu S.
        • Ling L.H.
        • Ullah W.
        • Hunter R.J.
        • Schilling R.J.
        • McLellan A.J.
        • et al.
        The Impact of Known Heart Disease on Long-Term Outcomes of Catheter Ablation in Patients with Atrial Fibrillation and Left Ventricular Systolic Dysfunction: A Multicenter International Study.
        Journal of Cardiovascular Electrophysiology. 2016; 27: 281-289
        View in Article
        • Addison D.
        • Farhad H.
        • Shah R.V.
        • Mayrhofer T.
        • Abbasi S.A.
        • John R.M.
        • et al.
        Effect of Late Gadolinium Enhancement on the Recovery of Left Ventricular Systolic Function After Pulmonary Vein Isolation.
        Journal of the American Heart Association. 2016; 5
        View in Article

      Article info

      Identification

      DOI: https://doi.org/10.1016/S1443-9506(18)30152-5

      Copyright

      © 2018 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX